CRISPR meets single-cell sequencing in new screening method

CRISPR meets single-cell sequencing in new screening method
Microfluidic droplets capture single, genome-edited cells and barcode their transcriptome. Credit: Paul Datlinger/CeMM

Genome editing using CRISPR/Cas9 "gene scissors" is a powerful tool for biological discovery and for identifying novel drug targets. In pooled CRISPR screens, a large number of cells are edited simultaneously using CRISPR guide-RNAs against thousands of different genes. Next, some of the edited cells are experimentally selected, and their guide-RNAs are counted to determine which genes are most important for the studied biological mechanism.

This screening method is most useful for addressing questions that are directly linked to a cell's ability to grow, for example identifying genes that protect cancer against chemotherapy or immune cells against HIV infection. In contrast, pooled screens are not well suited for studying gene regulation and other complex biological mechanisms. To understand how multiple genes work together to regulate cell state, it is currently necessary to grow, edit, and analyze cells separately for each CRISPR targeted gene, which is tedious and expensive.

In a new article published in Nature Methods, a team of CeMM scientists led by Christoph Bock now present a method that combines the strengths of pooled and arrayed CRISPR screens. By integrating CRISPR with single-cell RNA sequencing, they were able to determine the gene-regulatory impact of many genes in parallel, studying thousands of in a single experiment.

Bock's team succeeded with an elegant design that takes advantage of cutting-edge molecular technologies: The study's first author Paul Datlinger created a viral vector for making the CRISPR guide-RNAs visible in single-cell sequencing experiments, and the latest droplet-based methods for single-cell RNA sequencing provided sufficient throughput to characterize the effect of thousands of genome editing events in individual cells.

CRISPR meets single-cell sequencing in new screening method
A scientist in Christoph Bock's lab studying gene regulation. Credit: Wolfgang Däuble / CeMM

Creatively combining two of the most promising fields of genomics, the CROP-seq (for "CRISPR droplet sequencing") method enables high-throughput analysis of at a scale and detail that would be difficult to achieve with other methods. Furthermore, with falling single-cell sequencing costs, this technology could give rise to the first comprehensive maps of the regulatory effects for each of the 23,000 genes in the human genome.

"We will use CROP-seq to study the interplay of genetic and epigenetic factors in leukemia development", says Christoph Bock, advancing the laboratory's European Research Council (ERC) funded project on epigenome programming. "If we understand what it takes to make a cancer cell in the test tube, we can find new ways to interfere and revert cells to a less harmful state".

CROP-seq was developed as an open source method. All data, protocols, reagents and software that are part of CROP-seq will be freely shared by CeMM, enabling other scientists to use and extend the method in their own work. The ambition to making new methods as widely available as possible is part of CeMM's commitment to advancing biomedical research.


Explore further

Gene editing takes on new roles

More information: Paul Datlinger et al, Pooled CRISPR screening with single-cell transcriptome readout, Nature Methods (2017). DOI: 10.1038/nmeth.4177
Journal information: Nature Methods

Provided by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Citation: CRISPR meets single-cell sequencing in new screening method (2017, January 19) retrieved 20 June 2019 from https://phys.org/news/2017-01-crispr-single-cell-sequencing-screening-method.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments

Jan 25, 2017
Actually to gain more knowledge in the field, the following has to be attempted also. There are So Many types of Fish. Make Hybrids of Them using CRISPR & Feed to Pet Cats & Dogs To Study Their Influence. Meanwhile, Cell Biologists can Study Cells & Biochemical Aspects of Cells.
I think Money will not go to waste by this! This will attract Common man's interest and it can be extrapolated To Birds Too after 2 Decades once it is determined to be feasible!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more